Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Free cash flow yield
3Y CAGR
+14.8%/yr
Annual compound
Percentile
P78
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.83% | -53.8% |
| 2024 | 1.80% | +67.8% |
| 2023 | 1.07% | +95.4% |
| 2022 | 0.55% | +103.0% |
| 2021 | -18.18% | -45.2% |
| 2020 | -12.52% | +53.7% |
| 2019 | -27.03% | -159.9% |
| 2018 | -10.40% | -30.7% |
| 2017 | -7.96% | -129.9% |
| 2016 | -3.46% | - |